Dr. Kerry Rogers reviews recent chronic lymphocytic leukemia (CLL) treatment advances and explains how patients may benefit from evolving research.
Dr. Kerry Rogers is a Hematologist/Oncologist at The James Cancer Hospital and Solove Research Institute. More about this expert here:
Related Programs:
Tips for Determining the Best CLL Treatment for You
The Truth About CLL Treatment Options
What You Need to Know About Developing CLL Research
Chronic lymphocytic leukemia,CLL,symptoms leukemia,causes,treatment,therapy,prognosis,staging,RAI staging,stage I,stage II,stage III,stage IV,stage 1,stage 2,stage 3,stage 4,treatment response,IGHV,mutation,genetic mutation,genetics,genetic testing,genetic tests,genes,genomic tests,genomic,TP53,targeted therapy,chemoimmunotherapy,17p,
0 Comments